Latest News - Retina

Wednesday, May 24, 2017 | Retina

ProtoKinetix Completes First Year of Trials on Retinal Replacement Therapy Using AAGP

ProtoKinetix announced that it has completed the first year of retinal replacement therapy trials on animals and the results are encouraging enough to proceed to a second phase of testing. The stud…

Read the full story

Wednesday, May 17, 2017 | Retina

University of Birmingham: Eye Drops May Treat Age-Related Blindness

Scientists at the University of Birmingham in the UK say they have developed a type of eye drop that could potentially revolutionize the treatment of age-related macular degeneration (AMD), according …

Read the full story

Monday, May 15, 2017 | Medical Studies, Retina

Intravitreous Ranibizumab Cost-Effective for Some Patients With Proliferative Diabetic Retinopathy

Intravitreous ranibizumab appears to be cost-effective in patients with proliferative diabetic retinopathy (PDR) who have vision-impairing diabetic macular edema (DME), according to data from the Diab…

Read the full story

Tuesday, May 09, 2017 | Medical Studies, Retina

Robot Performs First-Ever Surgery Inside Human Eye

In a medical first, surgeons have used a robot to operate inside the human eye, greatly improving the accuracy of a delicate surgery to remove fine membrane growth on the retina. Such growth distorts …

Read the full story

Tuesday, May 09, 2017 | Medical Studies, Retina

Cell Replacement Could Restore Vision Lost to Neurodegeneration

Scientists have demonstrated the capacity to grow specialized neurons that relay visual data to the brain, creating a source of cells for future treatments of glaucoma and other optic neurodegenerativ…

Read the full story

Thursday, May 04, 2017 | Awards, Retina

NIH Launches Competition to Develop Human Eye Tissue in a Dish

The National Eye Institute (NEI), part of the National Institutes of Health, has opened the first stage of a federal prize competition designed to generate miniature, lab-grown human retinas. Over the…

Read the full story

Friday, April 21, 2017 | Partnerships, Retina, ThromboGenics

Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with ThromboGenics

Bicycle Therapeutics announced the receipt of a preclinical milestone in connection with the advancement of a Bicycle into preclinical development for the treatment of diabetic macular edema, under it…

Read the full story

Thursday, April 20, 2017 | Medical Studies, Retina

Okayama University Research: Successful Test of Retinal Prosthesis Implanted in Rats

Researchers at Okayama University report in the Journal of Artificial Organs the promising performance of a retinal prosthesis material when implanted in rats. The material is capable of converting ex…

Read the full story

Thursday, April 20, 2017 | Medical Studies, Retina

IBM Machine Vision Technology Advances Early Detection of Diabetic Eye Disease Using Deep Learning

IBM this week released the results of new research using deep learning and visual analytics technology to advance early detection of diabetic retinopathy (DR). The results, which classify the degree o…

Read the full story

Monday, April 17, 2017 | FDA Approval/Clearance, Retina, Genentech

FDA Approves Lucentis for All Forms of Diabetic Retinopathy

Genentech announced that the FDA has approved Lucentis (ranibizumab) 0.3 mg for the monthly treatment of all forms of diabetic retinopathy. With this approval, Lucentis becomes the first and only FDA-…

Read the full story

Monday, March 20, 2017 | Clinical Trials, Retina

NightstaRx Commences First Phase 1/2 Gene Therapy Clinical Trial for Patients with X-Linked Retinitis Pigmentosa

NightstaRx, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, today announces that the company has commenced enrolling and dosing subjects in a p…

Read the full story

Friday, March 17, 2017 | Earnings & Financials, Retina, Aerpio Therapeutics

Aerpio Pharmaceuticals Raises $40 Million

Aerpio Pharmaceuticals, a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced the successful completion of its reverse merger transaction with Aerpi…

Read the full story

Monday, March 13, 2017 | Clinical Trials, Retina

BioTime Expands OpRegen Clinical Trial in Dry AMD With Opening of First US Sites

BioTime announced the expansion of its ongoing phase 1/2a clinical trial for OpRegen in the advanced dry form age-related macular degeneration (AMD) by naming the first two sites that will treat patie…

Read the full story

Thursday, February 16, 2017 | Acquisitions/Mergers, Retina

BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Next-Generation Retinal Disease Therapy From University of Pittsburgh

BioTime announced that the company has obtained a worldwide license to intellectual property (IP) assets from University of Pittsburgh. The technology was developed in part in collaboration with BioTi…

Read the full story

Tuesday, February 14, 2017 | Earnings & Financials, Retina, Pixium Vision

Pixium Vision Receives NUB Innovation Reimbursement Status-1 for 150 Electrode IRIS II Bionic System in Germany

Pixium Vision announced that the German Institute for the Hospital Remuneration System (InEK) has granted NUB (Neue Untersuchungs- und Behandlungsmethoden) Status-1 for IRIS II, Pixium Vision’s …

Read the full story
Load More